Associated Papers
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.
Coates JT et al.
Cancer Discovery, 2021
34404686 (PubMed )
Supplement: candisc-11-2436-s001.pdf
Select a paper to view details